NCT06199869

Brief Summary

A growing number of patients develop atherosclerotic cardiovascular disease (ASCVD) despite the absence of standard modifiable risk factors (SMuRF-less). There is scarcity of studies that address this issue in the Middle Eastern population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,540

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 25, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 10, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

January 22, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2025

Completed
Last Updated

February 25, 2025

Status Verified

February 1, 2025

Enrollment Period

12 months

First QC Date

December 25, 2023

Last Update Submit

February 23, 2025

Conditions

Keywords

Atherosclerotic cardiovascular diseaseStandard modifiable risk factors (SMuRFs)Middle Eastern population

Outcome Measures

Primary Outcomes (1)

  • Prevalence of patients who do not any of the four SMuRFs

    Group of patients with definite ASCVD who do not have hypertension, diabetes, dyslipidemia or smoking.

    Up to 4 weeks after study enrollment

Interventions

Individuals identified with a diagnosis of ASCVD will fill a one page form of the associated risk factors they have

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

1. Adults (18 years of age and older) with ASCVD. 2. ASCVD includes: 1. Coronary heart disease 2. stroke 3. peripheral artery disease.

You may qualify if:

  • A diagnosis of atherosclerotic cardiovascular disease (ASCVD).
  • Ability to fill the clinical form that evaluates the presence or absence of cardiovascular risk factors including the 4 SMuRFs.

You may not qualify if:

  • Atherosclerotic cardiovascular disease diagnosed before the age of 18 years.
  • Inability to give detailed history of prespecified risk factors.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Istishari Hospital

Amman, 11184, Jordan

Location

Yarmouk University School of Medicine

Irbid, Jordan

Location

Related Publications (3)

  • Alrida NA, Albikawi Z, Alotaibi N, Alkouri O, Saifan AR, Jarrah M, Hammoudeh A, Khader Y, Alenezy A, Al-Zu'bi BM, Alharbi A, Alhalaiqa F, AbuRuz ME. Association of SMuRFs with cardiovascular risk factors, disease burden, and pharmacological management in Middle Eastern patients with ASCVD and a family history of premature CVD. Front Cardiovasc Med. 2025 Nov 27;12:1678767. doi: 10.3389/fcvm.2025.1678767. eCollection 2025.

  • Alkouri O, Alrida NA, Alabkal RM, Khader Y, Albikawi Z, Ababneh A, Alobaidly A, Qaladi O, Alharbi A, Jarrah M, Alotaibi N, Al-Bashaireh AM, Hammoudeh A, AbuRuz ME, Almustafa LA, Khraisat O, Al-Nsair N. Prevalence of physical activity and its association with atherosclerotic cardiovascular risk factors in young women in the middle east: a sub-analysis of the ANCHORS study. BMC Public Health. 2025 Oct 1;25(1):3268. doi: 10.1186/s12889-025-24595-y.

  • Hammoudeh AJ, Aldalal'ah M, Smadi EA, Alrishoud D, Alomari A, Alkhawaldeh M, Rizik A, Okour MF, Araydah M. Absence of Standard Modifiable Risk Factors in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease. The Jordan Absence of Standard Modifiable Risk Factors (SMuRF-Less) Study. Vasc Health Risk Manag. 2025 Feb 5;21:39-50. doi: 10.2147/VHRM.S499355. eCollection 2025.

MeSH Terms

Conditions

Atherosclerosis

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 25, 2023

First Posted

January 10, 2024

Study Start

January 22, 2024

Primary Completion

January 1, 2025

Study Completion

January 31, 2025

Last Updated

February 25, 2025

Record last verified: 2025-02

Locations